Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Statistics

Total Valuation

BCAX has a market cap or net worth of $1.04 billion. The enterprise value is $730.75 million.

Market Cap	1.04B
Enterprise Value	730.75M

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

BCAX has 54.78 million shares outstanding. The number of shares has increased by 1,559.37% in one year.

Current Share Class	54.78M
Shares Outstanding	54.78M
Shares Change (YoY)	+1,559.37%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	48.99%
Float	24.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.45
P/TBV Ratio	2.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.14, with a Debt / Equity ratio of 0.00.

Current Ratio	14.14
Quick Ratio	13.80
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.64% and return on invested capital (ROIC) is -19.28%.

Return on Equity (ROE)	-26.64%
Return on Assets (ROA)	-18.59%
Return on Invested Capital (ROIC)	-19.28%
Return on Capital Employed (ROCE)	-34.96%
Revenue Per Employee	n/a
Profits Per Employee	-$2.21M
Employee Count	55
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BCAX has paid $350,000 in taxes.

Income Tax	350,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-1.85%
50-Day Moving Average	15.30
200-Day Moving Average	12.81
Relative Strength Index (RSI)	64.42
Average Volume (20 Days)	642,596

Short Selling Information

The latest short interest is 6.46 million, so 11.79% of the outstanding shares have been sold short.

Short Interest	6.46M
Short Previous Month	5.68M
Short % of Shares Out	11.79%
Short % of Float	26.60%
Short Ratio (days to cover)	8.58

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-141.12M
Pretax Income	-121.17M
Net Income	-121.52M
EBITDA	-141.04M
EBIT	-141.12M
Earnings Per Share (EPS)	-$2.23

Balance Sheet

The company has $290.17 million in cash and $1.98 million in debt, giving a net cash position of $288.19 million or $5.26 per share.

Cash & Cash Equivalents	290.17M
Total Debt	1.98M
Net Cash	288.19M
Net Cash Per Share	$5.26
Equity (Book Value)	402.78M
Book Value Per Share	7.38
Working Capital	276.34M

Cash Flow

In the last 12 months, operating cash flow was -$112.98 million and capital expenditures -$82,000, giving a free cash flow of -$113.06 million.

Operating Cash Flow	-112.98M
Capital Expenditures	-82,000
Free Cash Flow	-113.06M
FCF Per Share	-$2.06

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,559.37%
Shareholder Yield	-1,559.37%
Earnings Yield	-11.93%
FCF Yield	-11.10%

Analyst Forecast

The average price target for BCAX is $26.20, which is 38.48% higher than the current price. The consensus rating is "Buy".

Price Target	$26.20
Price Target Difference	38.48%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-11.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1